Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W Adler

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Life Sciences|July 11, 2022
Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103Michael R Ruff, Saadet Inan, Xiang Qun Shi, et al.
Journal of Neuroimmunology|January 27, 2004
Paradoxes of immunosuppression in mouse models of withdrawalRahil T Rahim, Pu Feng, Joseph J Meissler, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 10, 2011
Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infectionJessica M Breslow, M Alexandra Monroy, John M Daly, et al.
Drug and Alcohol Dependence|December 27, 2011
Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neuronsG Cristina Brailoiu, Elena Deliu, Robert Hooper, et al.
Journal of Neuroimmunology|June 6, 2008
Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptorMatthew J Finley, Xiaohong Chen, Guiseppe Bardi, et al.
Journal of Neuroimmunology|June 5, 2002
Abrupt or precipitated withdrawal from morphine induces immunosuppressionRahil T Rahim, Martin W Adler, Joseph J Meissler, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2002
Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of painImre Szabo, Xiao-Hong Chen, Li Xin, et al.
Clinical Neurosurgery|March 3, 2009
Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injuryDarric E Baty, Ming Zhang, Hongbo Li, et al.
European Journal of Pharmacology|March 4, 2006
Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transitPu Feng, Rahil T Rahim, Alan Cowan, et al.
Military Medicine|February 20, 2020
Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain ManagementToby K Eisenstein, Xiaohong Chen, Saadet Inan, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Life Sciences|July 11, 2022
Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103Michael R Ruff, Saadet Inan, Xiang Qun Shi, et al.
Journal of Neuroimmunology|January 27, 2004
Paradoxes of immunosuppression in mouse models of withdrawalRahil T Rahim, Pu Feng, Joseph J Meissler, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 10, 2011
Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infectionJessica M Breslow, M Alexandra Monroy, John M Daly, et al.
Drug and Alcohol Dependence|December 27, 2011
Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neuronsG Cristina Brailoiu, Elena Deliu, Robert Hooper, et al.
Journal of Neuroimmunology|June 6, 2008
Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptorMatthew J Finley, Xiaohong Chen, Guiseppe Bardi, et al.
Journal of Neuroimmunology|June 5, 2002
Abrupt or precipitated withdrawal from morphine induces immunosuppressionRahil T Rahim, Martin W Adler, Joseph J Meissler, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2002
Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of painImre Szabo, Xiao-Hong Chen, Li Xin, et al.
Clinical Neurosurgery|March 3, 2009
Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injuryDarric E Baty, Ming Zhang, Hongbo Li, et al.
European Journal of Pharmacology|March 4, 2006
Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transitPu Feng, Rahil T Rahim, Alan Cowan, et al.
Military Medicine|February 20, 2020
Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain ManagementToby K Eisenstein, Xiaohong Chen, Saadet Inan, et al.
Pageof 6